TrialJournal for immunotherapy of cancer2021

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.

Sandra P D'Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.